Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| Humana Inc. | 23 | 0 | 5 | 0 | €299.30 | €439.88 | 46.968% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.27 | €19.86 | 216.825% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €99.70 | - | - |
| Rewalk Robotics Ltd. | 1 | 12 | 0 | 0 | €5.00 | - | - |
| Valneva SE | 2 | 0 | 0 | 0 | €3.44 | €7.00 | 103.252% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.50 | €5.76 | 64.469% |
| United Therapeutics | 18 | 0 | 3 | 0 | €240.90 | €288.66 | 19.826% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Avid Bioservices Inc | 2 | 0 | 1 | 0 | €7.15 | €8.75 | 22.378% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €24.20 | €29.29 | 21.045% |
| Novo Nordisk A/S ADR | 17 | 1 | 2 | 0 | €116.00 | €130.00 | 12.069% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €205.00 | - | - |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €92.18 | €99.50 | 7.941% |
| Select Medical Holdings | 4 | 0 | 2 | 0 | €26.00 | €36.41 | 40.025% |
| Twist Bioscience Corp | 4 | 0 | 1 | 0 | €29.86 | €40.70 | 36.318% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €85.50 | €97.90 | 14.505% |
| Cocrystal Pharma Inc. | 6 | 0 | 1 | 0 | €1.40 | €10.08 | 619.857% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €38.20 | €51.20 | 34.025% |
| Dexcom Inc. | 18 | 0 | 3 | 0 | €118.04 | €136.82 | 15.912% |
| Integer Hldg | 1 | 0 | 0 | 0 | €104.00 | - | - |
| Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.71 | €1.65 | -3.509% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.52 | €38.19 | 95.714% |